A mouse model of chronic idiopathic pulmonary fibrosis

61Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chronic idiopathic pulmonary fibrosis (IPF) is a progressive, fatal, and un-treatable disease with unclear etiology. There are few models of this chronic pathology, and although delivery of bleomycin to induce acute lung injury is the most common animal model of pulmonary fibrosis, there is considerable uncertainty about whether this acute injury resolves in those animals that sur-vive. In this report, we have systematically followed groups of mice for up to 6 months following a single insult of bleomycin. We assessed changes in lung function and pathology over this time course, with measurements of the diffu-sion capacity for carbon monoxide, lung mechanics, quantitative stereology, and collagen. Our results show that, while there is some repair over this extended time course, the injury in the lung never fully resolves. This persis-tent degree of fibrosis may have similarities to many features of human IPF. Thus, these chronic fibrotic changes in mouse lungs could be a useful model to evaluate potential therapeutic interventions to accelerate repair and possible treat this debilitating disease.

Cite

CITATION STYLE

APA

Limjunyawong, N., Mitzner, W., & Horton, M. R. (2014). A mouse model of chronic idiopathic pulmonary fibrosis. Physiological Reports, 2(2), 1–8. https://doi.org/10.1002/phy2.249

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free